Skip to main content
logo
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.26
+0.05 (0.69%)
At close: Jul 24, 2026, 4:00 PM EDT
7.05
-0.21 (-2.89%)
After-hours: Jul 24, 2026, 7:58 PM EDT

Aspire Biopharma Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
-0.01---
Revenue Growth
-----
Gross Profit
--0---
Operating Income
-2.77-19.35-1.21-1.34-0.98
Net Income
-2.53-24.48-1.31-1.34-0.98
Earnings Per Share
-548.27-491.40-57.00-0.032105.93
EPS Growth
-----

Revenue by Geography
Chart
Fiscal YearFY 2025
Period EndingDec '25
United States
0.01
Canada
0
United Kingdom
0
Total
0.01

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
00000.5
Total Debt
0.54.181.270.010
Net Cash (Debt)
-0.5-4.18-1.27-0.010.5
Net Cash Growth
-----
Net Cash Per Share
-0.81-83.79-55.09-9.68388.62

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-6.21-4.92-0.27-0.65-1.41
Free Cash Flow
-6.21-4.92-0.27-0.65-1.41
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
--1.87%---
Operating Margin
--312017.00%---
Pretax Margin
--394724.28%---
Profit Margin
--394725.00%---
FCF Margin
--79385.50%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
272.133005.84----